More on the FDA broadening its investigation into AstraZeneca COVID-19 vaccine candidate

Author: Eamonn Sheridan | Category: News

I covered the main points on this in an earlier post here: The US FDA has broadened its investigation into AstraZeneca COVID-19 vaccine candidate


Reuters have a report with further detail here:
  • AstraZeneca's large, late-stage U.S. trial has remained on hold since Sept. 6, after a study participant in Britain fell ill 
  • The widened scope of the FDA probe raises the likelihood of additional delays for what has been one of the most advanced COVID-19 vaccine candidates in development. The requested data was expected to arrive this week, after which the FDA would need time to analyze it, two of the sources said.

I covered the main points on this in an earlier post here: The US FDA has broadened its investigation into AstraZeneca COVID-19 vaccine candidate

For bank trade ideas, check out eFX Plus
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose